Small Business

Colgate-Palmolive Q3 net up 50% at Rs 116 cr

Personal and oral care products maker Colgate-Palmolive today reported a 50 per cent increase in net profit at Rs 116.39 crore in the third quarter ended December 31, 2009 over the same period last fiscal. - Tata Tea Q3 net declines 76% to Rs 92 cr - Apollo Hospitals Q3 net up 48% at Rs 44 cr - J&K Bank Q3 net up 16% to Rs 140 cr - Cairn India Q3 net up 23% to Rs 291 cr - BPCL Q3 profit declines 52% to Rs 379 cr - Central Bank Q3 dips 13% to Rs 306 cr The company had a net profit of Rs 77.74 crore in the third quarter ended December 31, 2008, Colgate-Palmolive said in a statement. During the quarter, the company had net sales of Rs 490.6 crore, a 17 per jump from Rs 419.2 crore recorded in the same period last fiscal. "The company"s continuing efforts and focused programmes to enhance efficiencies and reduce costs continue to yield strong, positive results and fund investments in strengthening brand equity and the business," it said. The company also attributed robust growth to healthy volumes witnessed by its flagship toothpaste brands like "Colgate Dental Cream", "Active Salt" and "Cibaca". "During the quarter, the company achieved a volume growth of 13 per cent, continuing its strong momentum in the toothpaste category, which grew by 15 per cent," the statement added.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Quarterly statements: Labour of love for governors?
Life for Reserve Bank of India (RBI) governors can be tough. Being the government’s money manager is hectic enough, but what have added to their “permanent state of busy-ness” (as an RBI observer says) are quarterly statements, the latest of which will be announced tomorrow.
Popular Articles

KPIT Cummins inks merger deal with Sparta Consulting
KPIT Cummins Infosystems Ltd, a global IT consulting and product engineering company, has entered into a definitive merger agreement with Sparta Consulting, a California, USA-based firm and a leading provider of high end SAP solutions. The all cash agreement is for a milestone based consideration of $38 million which includes a bonus of $4 million.

Dishman-Takamul JV aims $ 50 million by 2012
Dishman Arabia, the 50:50 joint venture between Dishman Pharmaceuticals & Chemicals and Saudi Arabia based Takamul, is bullish on touching a turnover of $50 million within two years of commencement of production at its JV plant in Riyadh.